MTOR and cancer: However, the activation of mTOR signaling in cancer cells is often due to mutations in oncogenes, such as in PI3K, Ras, and Raf, growth factor receptor kinases, autocrine growth factors5–7, and tumor suppressors such as PTEN, AMPK, TSC2, LKB1, and NF18, 9.